Model
Edge
Oyster Point Pharma Inc.
0001720725
Filing type
15-12G
Filing date
Jan 12, 2023
Updated
Jan 13, 2023 ยท 10:10 AM
Copy reference
Filing
15-12G
Notice of Suspension of Duty to File Reports